NEW YORK (GenomeWeb News) – Alere said today that it has been awarded a grant of up to $21.6 million and debt financing of up to $20.6 million from the Bill and Melinda Gates Foundation to further develop a pair of point-of-care molecular testing platforms.

Under the $21.6 million grant, Alere will develop a tuberculosis assay designed for use in both resource-poor and industrialized settings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.